Genevieve M. Spires Co-Authors Article in FDLI’s Update Magazine
The article explores the challenge that the pharmaceutical, biotechnology and medical device industry face when it comes to leaping into the world of social media. The problem, the article details, is that “social media is lighting fast, while the industry – due in large part to the regulations to which it is subject – must be more deliberate and is, therefore, much slower.”
Outlining multiple opportunities in which the industries could take advantage of social media, Spires and her co-author hope that the forthcoming FDA guidance will create a clear, adaptable and practical framework that will enable the pharmaceutical and other industries of the like to embrace the online environment and eliminate some of the uncertainties that currently exist in each industry.
Read the full article - "Exploring the Frontiers of Social Media While Awaiting FDA's Guidance" (Update Magazine, July/August 2013) Starts on page 28; Reprinted with Permission of FDLI.
Contributors
Related Services & Industries
- AFFORDABLE HOUSING AND COMMUNITY DEVELOPMENT
- ANTITRUST & TRADE REGULATION
- APPELLATE
- ATTORNEY UPDATE
- AUTONOMOUS & CONNECTED VEHICLES
- BANKRUPTCY & CREDITORS' RIGHTS
- BLOCKCHAIN & DIGITAL ASSETS
- BUCHANAN IP GUEST ASSOCIATE PROGRAM
- BUCHANAN LABS
- BUSINESS TAX
- CANNABIS
- CLASS ACTIONS
- COAL
- COMBINED HEAT & POWER (CHP)
- COMMERCIAL FINANCE
- CONSTRUCTION
- CONSUMER DEFENSE
- CONSUMER PRODUCTS
- CONTACT INFORMATION
- CONVERGENCE: M&A INSIGHTS IN HEALTHCARE
- COPYRIGHT
- CORONAVIRUS (COVID-19)
- CORPORATE
- CORPORATE COMPLIANCE
- CORPORATE TRANSPARENCY ACT
- CRIMINAL DEFENSE & GOVERNMENT ENFORCEMENT
- CYBERSECURITY & DATA PRIVACY
- DIVERSITY & INCLUSION
- DRUG TARGET ANALYSIS
- E-DISCOVERY
- EDUCATION
- EMERGING COMPANIES
- EMPLOYEE BENEFITS & ERISA
- EMPLOYMENT LITIGATION
- ENERGY
- ENTERTAINMENT, MEDIA & SPORTS
- ENVIRONMENTAL
- ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG)
- ESTATES & TRUSTS
- EXECUTIVE COMPENSATION
- FAMILY OFFICE
- FDA & BIOTECHNOLOGY
- FINANCE
- FRANCHISE & DISTRIBUTION
- GOVERNMENT RELATIONS & PUBLIC POLICY
- HEALTHCARE
- HEALTHCARE ADMINISTRATIVE & JUDICIAL PROCEEDINGS
- HEALTHCARE INFORMATION SECURITY & PRIVACY
- HEALTHCARE LITIGATION
- HEALTHCARE REGULATORY & COMPLIANCE
- HEALTHCARE TRANSACTIONS
- HOSPITALITY
- HR & EMPLOYEE RELATIONS ISSUES
- IMMIGRATION
- INNOVATIVE HEALTHCARE DELIVERY & PAYMENT
- INSIDER INSIGHTS: 100 DAYS OF BIDEN
- INSURANCE & REINSURANCE
- INTELLECTUAL PROPERTY
- INTERNAL INVESTIGATIONS
- INTERNATIONAL SERVICES
- INTERNATIONAL TAX
- INTERNATIONAL TRADE & NATIONAL SECURITY
- IP LITIGATION
- LABOR & EMPLOYMENT
- LIFE SCIENCES
- LIFE SCIENCES LITIGATION
- LITIGATION
- MANUFACTURING
- MARITIME & ADMIRALTY
- MATRIMONIAL & FAMILY LAW
- MERGERS & ACQUISITIONS
- NATIONAL SECURITY EXPORT CONTROLS AND ECONOMIC SANCTIONS
- NONPROFIT ORGANIZATIONS
- OIL & GAS
- OPPORTUNITY ZONES
- PASS-THROUGH ENTITIES
- PATENT COUNSELING & STRATEGIC ADVICE
- PATENT OFFICE LITIGATION
- PATENT PROCUREMENT
- POST-ACUTE & LONG-TERM CARE
- POWER GENERATION & UTILITY
- PRIVATE EQUITY AND VENTURE CAPITAL
- PRODUCT LIABILITY
- PUBLIC FINANCE
- PUBLIC PROCUREMENT & BID PROTESTS
- REAL ESTATE
- REAL ESTATE FINANCE
- REAL ESTATE TRANSACTIONS
- REIMBURSEMENT & MANAGED CARE
- RENEWABLES AND ALTERNATIVE ENERGY
- SECURITIES & SEC
- SECURITY ALARM
- SPORTS
- STATE & LOCAL TAX
- TAX
- TAX CONTROVERSY
- TECHNOLOGY, LICENSING AND COMMERCIAL CONTRACTS
- TITLE IX
- TRADE REMEDIES
- TRADE SECRETS & RESTRICTIVE COVENANTS